Labcorp has launched nationwide testing with Agilent’s FDA-approved PD-L1 IHC 22C3 pharmDx, enabling identification of patients with platinum-resistant ovarian cancer eligible for pembrolizumab immunotherapy.
BillionToOne has partnered with Epic to integrate its UNITY Complete prenatal and Northstar oncology tests into Epic’s EHR system, enabling direct ordering and results delivery for healthcare providers.
Partnership provides mail-in semen analysis as a covered benefit for eligible members.
Innovative IVF techniques are emerging to improve implantation predictions through non-invasive, AI-driven metabolomics assays.
Read More
hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights.
Read More
A Brazilian study used metabolomic analysis to identify metabolic alterations associated with different severities of preeclampsia.
Read More
The vaginal microbiome is a complex and dynamic ecosystem that varies across populations; research is limited by geographical disparities.
Read More
Yourgene Health has launched IONA Care+, a comprehensive non-invasive prenatal screening service in the UK, expanding its NIPT offerings.
Read More
Roche’s Elecsys sFlt-1/PlGF test received FDA clearance, providing a prognostic way to help ID pregnant women at risk of severe preeclampsia.
Read More
A new study suggests that neuroactive steroid levels in the third trimester may predict postpartum depression risk.
Read More
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read More
New research reveals that the saliva of pregnant women shows differences in their oral microbiome based on their levels of life stress.
Read More
A study found that faster blood processing could double the detection of gestational diabetes, reducing complications for mothers and babies.
Read More
NIH researchers found undetected cancers in nearly half of pregnant people with abnormal prenatal cfDNA test results.
Read More
Researchers identified genes closely linked to both rheumatoid arthritis and osteoporosis, offering diagnostic markers for these diseases.
Read More
The biomarker could enable prenatal detection of single ventricle heart disease through a maternal blood test for earlier diagnosis.
Read More
A blood test measuring the fibrinogen-to-albumin ratio can predict the risk of preeclampsia in laboring women, improving maternal outcomes.
Read More
Researchers discovered a potential stool test and therapy for endometriosis, based on bacterial metabolites linked to the condition.
Read More